The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFusion Antibody Share News (FAB)

Share Price Information for Fusion Antibody (FAB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.40
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.20 (6.061%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 3.40
FAB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Qatar's market manipulation fears fuelled by "abnormal" derivative moves-bank CEO

Wed, 04th Apr 2018 08:00

* Qatar c. bank probing market manipulation during Gulfstandoff

* Qatar's top bank helping central bank with probe

* QNB says has repaid cash injection

By Dmitry Zhdannikov and ghaida ghantous

DOHA, April 4 (Reuters) - Qatar's top bank QNB ishelping the country's authorities with data and expertise toprobe if Qatar's neighbours manipulated its markets, includingcredit default swaps (CDS), during a political standoff lastyear, its CEO told Reuters.

Qatar's central bank said in December it had launched alegal investigation into attempts by countries opposed to it toharm the Qatari economy by manipulating the currency, securitiesand derivatives markets.

Qatar National Bank (QNB) Chief Executive Ali Ahmedal-Kuwari said in an interview there had been unusual moves inQatari CDS late last year.

"The behaviour was abnormal ... the way it was moving veryfast, this is not normal behaviour. The dust around the crisissettled after two months, but the CDS continued to go up for noreason," he said, estimating the Qatari CDS market at $21billion.

Al-Kuwari said QNB was cooperating with the central bank inits investigation and had been "supplying them with anyinformation or data they asked us to supply them with."

QNB, the Middle East's largest lender by assets, is 50percent owned by the Qatar Investment Authority, Qatar'ssovereign wealth fund.

Saudi Arabia, the United Arab Emirates, Bahrain and Egyptimposed an economic boycott on Qatar last June, accusing it ofbacking terrorism, which it denies. The boycott led to thewithdrawal of billions of dollars of deposits from Qatari banks.

Last month, Qatar's central bank asked U.S. regulators toinvestigate the U.S. unit of the largest bank in the United ArabEmirates, accusing it of "bogus" foreign exchange deals designedto harm its economy as part of a blockade by Gulf neighbors.

First Abu Dhabi Bank, parent of the U.S.subsidiary, NBAD Americas, denied it had tried to manipulate theQatari riyal.

The request for a U.S. investigation deepened the diplomaticcrisis between Qatar, a major gas exporter, and its Gulfneighbours.

Asked if there was concern about further attempts tomanipulate Qatar's economy, al-Kuwari said: "This is a majoroffence. People will have to think about the consequences. Andespecially now with the legal case on the table, I assume peoplewill think twice before going further into these actions."

Al-Kuwari said that despite a substantial withdrawal ofdeposits at the start of the Gulf crisis in the middle of lastyear, deposits at QNB grew 13 percent for the whole of 2017.

He said the trend will likely be sustained in the firstquarter across the entire Qatari banking sector thanks to higheroil and gas prices and renewed confidence in the economy.

Al-Kuwari said QNB had repaid a cash injection it receivedfrom Qatar's central bank at the peak of the crisis last year.

He did not give the amount but said it represented a fairshare among Qatari banks. He said the overall injection amountedto around $20 billion for the whole of the banking sector, halfof which is controlled by QNB.

Qatar was able to beat the crisis partly thanks to a bigcash buffer of $350 billion in central bank reserves and assetsat the Qatar Investment Authority, which include stakes in majorcompanies including Glencore and Volkswagen.(Editing by Adrian Croft)

More News
30 Apr 2024 19:54

EARNINGS AND TRADING: Software Circle & Beximco report higher revenue

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
15 Apr 2024 13:29

Fusion Antibodies inks commercial contract for OptiPhage library

(Alliance News) - Fusion Antibodies PLC on Monday said that it has signed a commercial contract to develop an OptiPhage library for a non-human antibody species.

Read more
27 Feb 2024 14:18

TRADING UPDATES: Sondrel wins USD23 million contract

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
27 Feb 2024 13:15

Fusion Antibodies gets first order under new services agreement

(Sharecast News) - Fusion Antibodies announced the receipt of its first purchase order under a master services agreement on Tuesday, which it agreed with a prominent diagnostics company on 14 February.

Read more
14 Feb 2024 12:52

Fusion Antibodies raises £1.38m as it seeks new customers

(Sharecast News) - Pre-clinical antibody specialist Fusion Antibodies announced a conditional fundraising of £1.38m before expenses on Wednesday, to help it target mo re industry conferences and customers and generate further supporting data.

Read more
14 Feb 2024 11:27

IN BRIEF: Fusion Antibodies raises GBP1.4 million via placing

Fusion Antibodies PLC - Belfast-based contract researcher, which provides discovery, design and optimisation services for therapeutic antibodies to the healthcare market - Conditionally raises GBP1.4 million before expenses via placing of 34.4 million shares at 4 pence each. The issue price represents a discount of 5.9% to Fusion's closing mid-market share price on Tuesday. Further, it intends to issue 1.5 million new shares to certain directors in lieu of or in satisfaction of salary and fees due to them and which shall be issued immediately following publication of its announcement. Also intends to grant a total of up to 3.8 million new share options to staff and senior management.

Read more
6 Feb 2024 11:48

Fusion Antibodies strikes follow-on research and development project

(Alliance News) - Fusion Antibodies PLC on Tuesday said it has won a follow-on project under a collaborative research and development agreement with an unnamed "US-based biotechnology company".

Read more
6 Feb 2024 10:05

AIM WINNERS & LOSERS: Beeks Financial Cloud is ahead of expectations

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.

Read more
1 Feb 2024 16:27

Fusion Antibodies confirms £0.28m tax credit

(Sharecast News) - Preclinical antibody discovery specialist Fusion Antibodies announced the successful receipt of a research and development tax credit from HMRC on Thursday.

Read more
1 Feb 2024 12:00

Fusion Antibodies gets tax credit from UK HMRC for OptiMAL platform

(Alliance News) - Fusion Antibodies PLC on Thursday announced the receipt of a research & development tax credit from UK HM Revenue & Customs for work performed on the development of its OptiMAL platform and other projects in bioinformatics.

Read more
4 Dec 2023 16:56

LONDON MARKET CLOSE: FTSE 100 slips as miners hold down index

(Alliance News) - Stock prices in London closed lower on Monday, with miners and oil firms holding down the FTSE 100 index.

Read more
4 Dec 2023 12:01

Fusion Antibodies revenue falls, losses widen in first half

(Sharecast News) - Contract research organisation Fusion Antibodies reported first-half revenue of £0.54m on Monday, down from £1.9m a year earlier.

Read more
4 Dec 2023 10:23

AIM WINNERS & LOSERS: Cornerstone FS to beat 2023 expectations

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

Read more
4 Dec 2023 10:22

Fusion Antibodies shares fall with revenue despite "positive" outlook

(Alliance News) - Fusion Antibodies PLC on Monday reported a widened loss and reduced revenue for its latest half year, but said its growth prospects are "increasingly positive".

Read more
28 Nov 2023 12:09

Fusion Antibodies shares up on deal with US National Cancer Institute

(Alliance News) - Fusion Antibodies PLC on Tuesday said it has signed a collaboration agreement with the US National Cancer Institute to use its OptiMAL product to discover novel antibodies to treat certain targets.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.